PBLCX
Price
$44.74
Change
+$0.23 (+0.52%)
Updated
Jul 25 closing price
Net Assets
11.66B
VIGRX
Price
$233.81
Change
+$1.03 (+0.44%)
Updated
Jul 25 closing price
Net Assets
311.95B
Interact to see
Advertisement

PBLCX vs VIGRX

Header iconPBLCX vs VIGRX Comparison
Open Charts PBLCX vs VIGRXBanner chart's image
Principal Blue Chip C
Price$44.74
Change+$0.23 (+0.52%)
VolumeN/A
Net Assets11.66B
Vanguard Growth Index Investor
Price$233.81
Change+$1.03 (+0.44%)
VolumeN/A
Net Assets311.95B
PBLCX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PBLCX vs. VIGRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBLCX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 312B vs. PBLCX (11.7B). VIGRX pays higher dividends than PBLCX: VIGRX (0.34) vs PBLCX (0.00). PBLCX was incepted earlier than VIGRX: PBLCX (12 years) vs VIGRX (33 years). PBLCX (1.69) is less costly to investors than VIGRX (0.17). PBLCX is a more actively managed with annual turnover of: 14.70 vs. VIGRX (11.00). PBLCX has a lower initial minimum investment than VIGRX: PBLCX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 26.62 vs. PBLCX (16.27). VIGRX return over 5 years is better than : 116.11 vs. PBLCX (56.60).
PBLCXVIGRXPBLCX / VIGRX
Total Expense Ratio1.660.17976%
Annual Report Gross Expense Ratio1.690.17994%
Fund Existence12 years33 years-
Gain YTD11.48810.658108%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets11.7B312B4%
Annual Yield % from dividends0.000.34-
Returns for 1 year16.2726.6261%
Returns for 3 years67.3194.3871%
Returns for 5 years56.60116.1149%
Returns for 10 years176.69314.9056%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDV17.140.33
+1.96%
Indivior PLC
ALNT39.740.46
+1.17%
Allient
RF26.420.12
+0.46%
Regions Financial Corp
IBIO0.73-0.01
-0.88%
iBio
IKT1.77-0.08
-4.32%
Inhibikase Therapeutics